EGFR L858R Mutation May Go Undetected Because of P848L in cis Mutation

被引：6
|
作者：
Santamaria, Inigo [1 ]
Menendez, Sofia T.
Balbin, Milagros
机构：
[1] Hosp Univ Cent Asturias, Oviedo, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 26期
关键词：
CELL LUNG-CANCER; RARE;
D O I：
10.1200/JCO.2012.47.3512
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E420 / E421
页数：2
相关论文
共 50 条
  • [1] Highly sensitive detection of EGFR L858R mutation at the mRNA level
    Mai Pham
    Quynh Pham
    Ung Nguyen
    Lanh Nguyen
    Hoa Nguyen
    Thang Vu
    Ba Nguyen
    Stenman, Jakob
    Ho Tho
    [J]. ANALYTICAL BIOCHEMISTRY, 2022, 654
  • [2] Association of EGFR L858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial
    Karachaliou, Niki
    Mayo-de las Casas, Clara
    Queralt, Cristina
    de Aguirre, Itziar
    Melloni, Boris
    Cardenal, Felipe
    Garcia-Gomez, Ramon
    Massuti, Bartomeu
    Miguel Sanchez, Jose
    Porta, Ruth
    Ponce-Aix, Santiago
    Moran, Teresa
    Carcereny, Enric
    Felip, Enriqueta
    Bover, Isabel
    Insa, Amelia
    Reguart, Noemi
    Isla, Dolores
    Vergnenegre, Alain
    de Marinis, Filippo
    Gervais, Radj
    Corre, Romain
    Paz-Ares, Luis
    Morales-Espinosa, Daniela
    Viteri, Santiago
    Drozdowskyj, Ana
    Jordana-Ariza, Nuria
    Luis Ramirez-Serrano, Jose
    Angel Molina-Vila, Miguel
    Rosell, Rafael
    [J]. JAMA ONCOLOGY, 2015, 1 (02) : 149 - 157
  • [3] A Novel Dual-labeled Peptide for Multimodal Imaging of EGFR with L858R Mutation
    Kim, Myoung Hyoun
    Kim, Seul-Gi
    Kim, Dae-Weung
    [J]. CURRENT RADIOPHARMACEUTICALS, 2024, 17 (02) : 174 - 183
  • [4] Almonertinib Combined with Anlotinib and Temozolomide in a Patient with Recurrent Glioblastoma with EGFR L858R Mutation
    Hou, Zhiwei
    Wu, Huaguo
    Luo, Ningning
    Li, Shuo
    Zhang, Xiang
    Dong, Shuai
    Zhu, Dongyuan
    Zhang, Hui
    Tao, Rongjie
    [J]. ONCOLOGIST, 2023, 28 (05): : 449 - 452
  • [5] Comparison of uncommon EGFR exon 21 L858R compound mutations with single mutation
    Peng, Liang
    Song, Zhigang
    Jiao, Shunchang
    [J]. ONCOTARGETS AND THERAPY, 2015, 8 : 905 - 910
  • [6] Lung adenocarcinoma with EGFR L858R-K860I and L858R-L861F doublet mutations from which the L858R mutation is undetectable through the cobas EGFR mutation test v2
    Wu, Chi-Hsuan
    Zhang, Man-San
    Huang, Yen-Lin
    Cheng, Wei-Hsiang
    Lai, Jin-Yao
    Hsieh, Min-Shu
    Liao, Wei-Yu
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2024, 257
  • [7] Validation steps for the detection of L858R mutation in EGFR gene by real time quantitative PCR
    Saitta, Emeline
    Brasselet, Astrid
    Cadouot, Muriel
    Gibeaud, Anne
    Jourdain, Marine
    Bozonnet, Didier
    Goussot, Vincent
    Riedinger, Jean-Marc
    Lizard, Sarab
    [J]. ANNALES DE BIOLOGIE CLINIQUE, 2016, 74 (02) : 196 - 202
  • [8] Synchronous Double Primary Lung Adenocarcinomas With EGFR L858R Point Mutation and MET Exon 14 Skipping Mutation
    Ando, Seijitsu
    Futami, Shinji
    Azuma, Koji
    Nishimatsu, Kanako
    Shirasaka, Takuma
    Minami, Seigo
    [J]. JOURNAL OF MEDICAL CASES, 2024, 15 (08) : 153 - 158
  • [9] Acquired gefitinib-resistant mutation of EGFR in a chemonaive lung adenocarcinoma harboring gefitinib-sensitive mutation L858R
    Gow, CH
    Shih, JY
    Chang, YL
    Yu, CJ
    [J]. PLOS MEDICINE, 2005, 2 (09): : 924 - 925
  • [10] First case report of erlotinib plus ramucirumab treatment for lung carcinosarcoma with EGFR L858R mutation
    Ishibashi, Naoya
    Tabata, Toshiharu
    Nonomura, Ryo
    Oshima, Yutaka
    Sasaki, Takanobu
    Mitomo, Hideki
    Sugawara, Takafumi
    Sagawa, Motoyasu
    [J]. THORACIC CANCER, 2023, 14 (34) : 3415 - 3418
12345